Researchers have developed an AI model that accurately predicts which keratoconus patients require treatment by analyzing OCT eye scans and clinical data.
Key Details
- 1Study presented at the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS).
- 2AI analyzed 36,673 OCT images from 6,684 patients with keratoconus.
- 3Algorithm could stratify two-thirds of patients as low-risk and one-third as high-risk for disease progression using data from a single visit.
- 4Including data from a second visit increased prediction accuracy to up to 90% of patients correctly categorized.
- 5Cross-linking treatment prevents vision loss and corneal transplantation in most cases if given early.
- 6Algorithm will undergo further safety testing before clinical deployment; researchers plan to expand to other eye conditions.
Why It Matters
Accurate early prediction of keratoconus progression through AI-augmented imaging could enable timely intervention, reduce unnecessary monitoring, and optimize healthcare resources, potentially preventing vision loss in young patients. This approach showcases the growing clinical impact of AI in ophthalmic imaging and patient stratification.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.